All In MedTech

Device Trial Radar · NCT05611099

Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.

Assessment of the Stability, Robustness and Usability of the Dreem 3 System for EEG Sleep Monitoring in the Home Setting, in an Insomnia Population.

Last checked: Nov 20, 2026Latest source record: Nov 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

15

Actual

Start

Aug 15, 2022

Primary completion

Oct 31, 2022

Study completion Nov 5, 2022

Sponsor

Lead sponsor
DreemNot on our public-company list
Sponsor type
Industry
First posted
Nov 9, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

There is an unmet medical need for monitoring sleep for multiple nights in a patient's home, without the inconvenience of traveling and staying overnight in a medical center, and without the need for a technician to set up a polysomnography (PSG) device at the patient's home. Several disorders, and particularly sleep disorders, are associated with insomnia symptoms, and longitudinal sleep assessment may support a better understanding and management of these patients, who currently seldom access sleep lab PSG. On one hand, this study aims at demonstrating whether the final device's user interface supports safe and effective use when being used at home over multiple nights. On the other, the study aims at confirming that stable and consistent data are measured in the device's actual use, for the records to be clinically usable in daily practice.

Conditions

  • Insomnia, Secondary
  • Sleep Disturbance
  • Sleep
  • Sleep Initiation and Maintenance Disorders

Interventions

  • Dreem 3 System vs WatchPAT OneDevice

    Dreem 3 System and WatchPAT One will be worn simultaneously during 3 nights by each study participant, in order to compare the TST automatically outputted by both devices.

  • Usability QuestionnaireOther

    After having undergone the 3 nights of measurement, an end of Study Questionnaire will be performed on a separate day to obtain Usability feedback from participants who have undergone simultaneous recordings with the Dreem 3 + WatchPAT devices.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TST CorrelationTime frame: 3 nights
  2. Dreem 3 System usabilityTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dreem Health

    Encinitas, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.